Abstract
Clomethiazole is widely used in European countries to treat alcohol withdrawal symptoms including delirium tremens. The current study aimed to explore the effects of clomethiazole on the sleep of healthy volunteers. We postulated both a hypnotic and a REM suppressive effect as well as the occurrence of a rebound phenomenon following three days of treatment with clomethiazole. The study group was composed of five men and five women. The probands were examined in the sleep laboratory throughout a course of seven nights. The first night was considered as the adaptation night and the second as the baseline night. Prior to nights 3 to 5, probands took 384 mg clomethiazole at 22 hours. The 6th and 7th nights served to record potential effects of medication discontinuation.
The current study confirms the indication in the scientific literature with regard to hypnotic and REM–suppressive effects of clomethiazole, as well as a rebound phenomenon following discontinuation of the medication. The effect of clomethiazole on the sleep EEG was most obvious in the first half of the night. The analysis of the polysomnogram in terms of each half of the night gave no indication of a rebound phenomenon during the second half.
The REM sleep–suppressing component of clomethiazole is of great interest in connection with its use in treating delirium tremens. The rebound phenomenon in healthy controls after only three days of medication at a relatively low dosage of clomethiazole underscores the need to administer it in doses individually tailored to the extent of the alcohol withdrawal syndrome in the individual patient.
Similar content being viewed by others
References
Aguayo LG, Peoples RW, Yeh HH, Yevemes GE (2002) GABA (A) receptors as molecular sites of ethanol action. Director indirect actions. Curr Top Med Chem 8:869–885
Bayer AJ, Bayer EM, Pathy MS, Stoker MJ (1986) A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly. Acta Psychiatr Scand 329(Suppl):104–111
Braunwarth WD (1990) Indikationen für den Einsatz von Clomethiazol. Fortschr. Med 108:504–506/10:9104
Brower KJ, Aldrich MS, Hall JM (1998) Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcoholism: Clin Exp Res Vol 22:1864–1871
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1988) The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research 28:193–213
Clark CP, Gillin JC, Goshan S, et al. (1988) Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry 43:601–607
Dehlin O (1986) Hypnotic effect of chlormethiazole in geriatric patients during long-term treatment. Acta Psychiatr Scand 329 (Suppl):112–115
Drummond SPA, Gillin JC, Smith TL, Demodena A (1998) The sleep of abstinent pure primary alcoholic patients: Natural course and relationship to relapse. Alcohol Clin Exp Res 22:1796–1802
Evans JL, Lewis SA, Tinker M (1972) Chlormethiazole, sleep and drug withdrawal. Psychol Med 2:239–247
Foster JH, Peters TJ (1999) Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res 23:1044–1051
Gann H, Kiemen A, Klein T, Ebert D, Backhaus J, Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1997) Schlaf und cholinerger REM-Schlaf-Induktionstest bei Patienten mit primärer Alkoholabhängigkeit. Somnologie 1:119–125
Gann H, Faulmann A, Kiemen A, Klein T, Ebert D, Backhaus J, Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1998) Sleep and the cholinergic REM sleep induction test in patients with primary alcoholism. Sleep Research Online 1:92–95
Gann H, Gardziella S, Backhaus J, Hohagen F, Riemann D (1999) Der Schlaf und seine cholinerge Beeinflußbarkeit bei Patienten mit primärer Alkoholabhängigkeit im subakuten Entzug. Sucht 45:89–99
Gann H, Feige B, Hohagen F, van Calker D, Geiss D, Riemann D (2001) Sleep and the cholinergic REM sleep induction test in patients with primary alcoholism. Biol Psychiatry 50:383–390
Gann H, Feige B, Fasihi S, van Calker D, Voderholzer U, Riemann D (2002) Periodic limb movements during sleep in alcohol dependent patients. Eur Arch Psychiatry Clin Neurosci 252:124–129
Gann H, Feige B, Cloot O, Wasen van H, Zinzgraf D, Hohagen F, Riemann D (2004) Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients – a double- blind- and randomized study. Pharmacopsychiatry 37(5):228–235
Gann H, Feige B, Brück R, Litsch S (2005) Hohagen F, Riemann D The effect of alcohol on polysomnographically recorded sleep in healthy subjects (in preparation)
Gillin JC, Smith TL, Irwin M, et al. (1994) Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in non-depressed patients with primary alcoholism at 3- month follow up. Arch Gen Psychiatry 51:189–197
Görtelmeyer R (1981) Schlaffragebogen SF-A und SF-B. In: Collegium Internationale Psychiatriae Scolarum (CIPS). Herausgeber. Internationale Skalen für Psychiatrie. Beltz, Weinheim, pp 357
Grace J (1999) Chlormethiazole, apnoea and Alheimer’s disease. Acta Psychiatr Scand 100(3):248
Gregg E, Akther I (1979) Chlormethiazole Abuse. Brit J Psychiatry 134:627–629
Grenn AR (1998) Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol Ther 80:123–147
Hautzinger M, Bader M, Worall H, Keller F (1995) Beck-Depressions- Inventar. Hans Huber, Bern
Kaldune A, Strnad J, Cornu C, Bahro M (1999) Apnea syndrome in a patient with Alzheimer dementia under chlormethiazole treatment: a clinical experience report. Acta Psychiatr Scand 99 (1):79–81
Laux L, Glanzmann P, Schaffner P, Spielberger CD (1981) State- Trait-Angstinventar (STAI) Weinheim Beltz Testgemeinschaft
Liljenberg B, Almqvist M, Broman JE, Hetta J, Roos BE (1986) The effects of chlormethiazole in EEG recorded sleep in normal elderly volunteers. Acta Psychiatr Scand 329(Suppl):34–39
Majumdar SK (1990) Chlormethiazole: Current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alc Dep 27:201–207
Morgan MY (1995) The management of alcohol withdrawal using chlormethiazole. Alcohol Alcohol 30:771–774
Nelson, RM, Green AR, Hainsworth AH (2002) Electrophysiological actions of gamma-aminobutyric acid and chlormethiazole on recombinant GABAA receptors. Eur J Pharmacol 452:255–262
Overstall PW, Oldman PN (1987) A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age Ageing 16:45–51
Pace-Schott EF and Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3:591–605
Pathy MS, Bayer AJ, Stoker MJ (1986) A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances. Acta Psychiatr Scand 329(Suppl):99–103
Reilly TM (1976) Physiological dependence on and symptoms of withdrawal from chlormethiazole. Brit J Psychiatry 128:375–378
Riemann D, Backhaus J (1996) Behandlung von Schlafstörungen – ein psychologisches Gruppenprogramm. Beltz, Weinheim
Roehrs T, Papineau K, Rosenthal L, Roth T (1999) Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacol 20:279–86
Stuppaeck C, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Withworth A, Fleichhaker W (1995) Eine modifizierte und ins Deutsche übersetzte Form der Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-A). Wien Ztschr Suchtforsch 18:39–48
Usala M, Thompson A, Whiting PJ, Wafford KA (2003) Activity of chlormethiazole at human recombinant GABAA and NMDA receptors. Br J Pharmacol 140:1045–1050
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gann, ., Hartig, K., Feige, B. et al. The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects. Eur Arch Psychiatry Clin Neurosci 255, 284–290 (2005). https://doi.org/10.1007/s00406-005-0589-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-005-0589-3